About KidneyX
KidneyX: The Kidney Innovation Accelerator
The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.
What We Do
Mission
Accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases
Principles
- Mission Driven
Ensure all product development is patient-centered - Achievable
Ground in scientifically-driven technology development - Additive
Address barriers to innovation that are not addressed by the public or private sectors - Urgent
Create a sense of urgency to meet the needs of people with kidney diseases - Catalytic
Reduce risks to incentivize further investments in kidney space - Collaborative
Foster multidisciplinary and multi-sector teamwork
Milestones in KidneyX History
2014
ASN testified to House Committee on prizes that advance kidney replacement therapy
2016
ASN committed to serving as Secretariat of a kidney innovation accelerator at the White House Organ Summit
2018
ASN and HHS formalized KidneyX via Memorandum of Understanding, hosted inaugural KidneyX Summit
2019
KidneyX received first $5M appropriation for FY 20
2020
2021
KidneyX included in President Biden’s first federal budget proposal ($5M)
The pace of innovation in kidney care has been unacceptable. Through KidneyX, we are creating a clear path for disruptive innovation in a $114 billion market.
Join Us
Whether you’re a researcher, innovator, investor, patient, caregiver, or care partner, be a part of the KidneyX solution.
